Edgewise Therapeutics, Inc. (EWTX)
30.44
+0.78
(+2.63%)
USD |
NASDAQ |
Feb 27, 16:00
30.11
-0.33
(-1.08%)
After-Hours: 07:25
Edgewise Therapeutics Shareholders Equity (Quarterly) : 522.26M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Glaukos Corp. | 656.16M |
| Nuvalent, Inc. | 1.248B |
| Neurocrine Biosciences, Inc. | 3.253B |
| Omeros Corp. | -220.48M |
| Agios Pharmaceuticals, Inc. | 1.193B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 552.60M |
| Total Liabilities (Quarterly) | 30.35M |
| Debt to Equity Ratio | 0.0076 |
| Current Ratio | 19.85 |
| Net Debt Paydown Yield | 0.00% |